spacer
home > ict > autumn 2020 > pci pharma services’ game-changing digital platform
PUBLICATIONS
International Clinical Trials

PCI Pharma Services’ Game-Changing Digital Platform

The pharmaceutical industry has historically been risk-averse and slow to adopt technology. PCI Pharma Services is blazing a trail in digitalisation, with everything from real-time supply-chain information, supplier communities, and smart packaging, to virtual audits of their facilities.

“PCI Pharma Services is recognised in the industry as a leader when it comes to providing world-class customer service,” said Wayne Hull, Global Chief Digital and Technology Officer at PCI. “In order to retain that leadership position going forward, digital experiences and capabilities are essential.”

PCI is now a year into its three-year corporate digital transformation strategy that is already differentiating the company, and providing real and measurable returns. Case in point, they recently launched a milestone achievement: an innovative, first of its kind, digital customer platform that will completely transform the customer experience – pci | bridge.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
PCI is committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively. Its clients come seeking solutions to often complex and unique opportunities due to its reputation in offering unmatched flexibility, a client-centric experience, and consultative approach, delivering a seamless clinical service including pharmaceutical development, clinical manufacturing, labelling, storage, and distribution. Your bridge between lifechanging therapies and patients.

Print this page
Send to a friend
Privacy statement
News and Press Releases

Language Weaver now available for ServiceNow customers

RWS, the world’s leading provider of technology-enabled language, content management, and intellectual property services, has released a new Language Weaver Connector for ServiceNow
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement